logo
[breadcrumb_custom]

Tag: NASDAQ:MYMD

Industry

MYMD’s 2023 Market Dance: Down -53.23% – Time to Invest?

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. Until today this year the stock’s price performance recorded a decrease of -53.23%. However, over the last six months, the performance has been stronger by -90.90%. The price of MYMD decreased -38.58% over the last 30 days. And in the last five days, it has fallen by -13.20%. MyMD Pharmaceuticals Inc’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $2.41 on 02/15/23, and the lowest price during

Industry

Behind MyMD Pharmaceuticals Inc’s 52-Week Range: Uncovering Opportunities for Investors

The market performance of MyMD Pharmaceuticals Inc has been somewhat unstable. Over the past year, the company’s stock achieved a high of $2.98 on 02/02/23, with the lowest value for the same timeframe being $0.16, recorded on 01/26/24. 52-week price history of MYMD Stock A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. MyMD Pharmaceuticals Inc’s current trading price is -94.74% away from its 52-week high, while its distance from the 52-week low is 0.84%. The stock’s price range during this period has fluctuated between $0.16 and $2.98. Shares

THMO
News

MyMD Pharmaceuticals Inc (MYMD) Stock: Navigating a Year of Stock Volatility

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. MyMD Pharmaceuticals Inc’s current trading price is -94.29% away from its 52-week high, while its distance from the 52-week low is 3.03%. The stock’s price range during this period has varied between $0.17 and $2.98. The company, active in the Healthcare sector, saw a trading volume of around 1.15 million for the day, considerably lower average daily volume of 1.44 million observed over the last three months. MyMD Pharmaceuticals Inc’s stock has seen a rocky